This issue sponsored by the Pacific Lipid Association Cardiovascular Risk and Dyslipidemia in Mexican-Americans Pharmacologic Treatment of Non-HDL-C and Goal Attainment 5Average: 5 (1 vote) This page was last updated: Mar 18, 2022